Literature DB >> 10504603

Strial dysfunction in the MRL-Fas mouse.

M J Ruckenstein1, M Milburn, L Hu.   

Abstract

The MRL-Fas(lpr) mouse, a model of multisystemic autoimmune disease, has been proposed as a potential model of autoimmune inner ear disease. Cochlear pathology, consisting of hydropic degeneration of the stria vascularis, has been documented to occur coincident with the establishment of systemic disease in this animal. Because the cochlear pathology is restricted to the stria, this study was designed to evaluate whether the endocochlear potential (EP) would be diminished in these animals because of a loss in strial Na, K-ATPase. Experimental (MRL-Fas(lpr)) mice, with established systemic disease, had auditory brain stem response thresholds and EPs recorded. MRL-+/+ mice served as controls. Animals were then euthanized, and their cochleas were processed for immunohistologic assay for the alpha1 and beta2 subunits of Na,K-ATPase. Density of staining was evaluated by use of quantitative means with densitometry image analysis of digitized images. MRL-Fas(lpr) mice revealed significant elevations in auditory brain stem response thresholds and reductions in EPs but no reductions in Na,K-ATPase levels, as evidenced by immunohistochemical assay. The reduction of EP likely occurs as a result of cellular degeneration within the stria vascularis and likely results from an abrogation of the strial perilymph/endolymph barrier and not from a reduction in strial Na, K-ATPase levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10504603     DOI: 10.1016/S0194-5998(99)70236-6

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  12 in total

Review 1.  Immunosuppressive therapy for autoimmune inner ear disease.

Authors:  Maria C Buniel; Katie Geelan-Hansen; Peter C Weber; Vincent K Tuohy
Journal:  Immunotherapy       Date:  2009-05       Impact factor: 4.196

2.  Vascular Pathophysiology in Hearing Disorders.

Authors:  Dennis R Trune; Anh Nguyen-Huynh
Journal:  Semin Hear       Date:  2012-08

Review 3.  Physiopathology of the cochlear microcirculation.

Authors:  Xiaorui Shi
Journal:  Hear Res       Date:  2011-08-23       Impact factor: 3.208

4.  Murine autoimmune hearing loss mediated by CD4+ T cells specific for inner ear peptides.

Authors:  C Arturo Solares; Andrea E Edling; Justin M Johnson; Moo-Jin Baek; Keiko Hirose; Gordon B Hughes; Vincent K Tuohy
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 5.  Mechanisms and genes in human strial presbycusis from animal models.

Authors:  Kevin K Ohlemiller
Journal:  Brain Res       Date:  2009-03-12       Impact factor: 3.252

Review 6.  Corticosteroid therapy for hearing and balance disorders.

Authors:  Dennis R Trune; Barbara Canlon
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

7.  Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss.

Authors:  Dennis R Trune; J Beth Kempton
Journal:  Audiol Neurootol       Date:  2009-11-16       Impact factor: 1.854

8.  Modulatory Effects of Mild Carbon Monoxide Exposure in the Developing Mouse Cochlea.

Authors:  Ivan A Lopez; Dora Acuna; John Edmond
Journal:  Neurochem Res       Date:  2016-03-19       Impact factor: 3.996

9.  Expression and dexamethasone-induced nuclear translocation of glucocorticoid and mineralocorticoid receptors in guinea pig cochlear cells.

Authors:  Sung-Hee Kil; Federico Kalinec
Journal:  Hear Res       Date:  2013-02-09       Impact factor: 3.208

10.  Strial microvascular pathology and age-associated endocochlear potential decline in NOD congenic mice.

Authors:  Kevin K Ohlemiller; Mary E Rybak Rice; Patricia M Gagnon
Journal:  Hear Res       Date:  2008-08-12       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.